Skip to main content
. 2015 Dec 2;2015(12):CD009172. doi: 10.1002/14651858.CD009172.pub2

Comparison 4. MS‐LE versus S‐LE.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Death before discharge 1 60 Risk Difference (M‐H, Fixed, 95% CI) 0.00 [‐0.06, 0.06]
4.2 Days to regain birth weight 1 60 Mean Difference (IV, Fixed, 95% CI) 1.00 [‐1.53, 3.53]
4.3 Rate of weight gain (g/kg/day) 1 60 Mean Difference (IV, Fixed, 95% CI) ‐2.67 [‐8.20, 2.86]
4.4 Bronchopulmonary dysplasia/chronic lung disease 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 1.00 [0.28, 3.63]
4.5 Any sepsis (clinical and/or culture positive) 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 2.00 [0.67, 5.94]
4.6 Necrotising enterocolitis (≥ stage 2) 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 5.00 [0.25, 99.95]
4.7 Any patent ductus arteriosus 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 1.13 [0.70, 1.82]
4.8 Parenteral nutrition associated liver disease/cholestasis 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 3.00 [0.13, 70.83]
4.9 Hypertriglyceridaemia 1 12 Risk Difference (M‐H, Fixed, 95% CI) 0.00 [‐0.27, 0.27]